Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients

Cancer Medicine

Volumn 4, Issue 3, 2015, Pages 354-362

  Hernandez, Brenda Y ^a   Wilkens, Lynne R ^a   Le Marchand, Loïc ^a   Horio, David ^b   Chong, Clayton D ^a,c   Loo, Lenora W M ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c QUEEN S MEDICAL CENTER   (United States)

Author keywords

Breast cancer; IGF1; IGF1R; IGFBP2; IGFBP3; Insulin axis protein; Multiethnic

Indexed keywords

SOMATOMEDIN; IGF1 PROTEIN, HUMAN; IGF1R PROTEIN, HUMAN; IGFBP-2 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER SURVIVAL; CAUCASIAN; ETHNIC GROUP; ETHNICITY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; NATIVE HAWAIIAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BREAST NEOPLASMS; ETHNOLOGY; HAWAII; METABOLISM; MIDDLE AGED;

ADULT; AGED; BREAST NEOPLASMS; ETHNIC GROUPS; FEMALE; HAWAII; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; RECEPTORS, SOMATOMEDIN;

EID: 84979851912     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.375     Document Type: Article

References (39)

1. Eheman, C., S. J. Henley, R. Ballard-Barbash, E. J. Jacobs, M. J. Schymura, A. M. Noone, et al. 2012. Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118:2338-2366.
2. Carey, L. A., C. M. Perou, C. A. Livasy, L. G. Dressler, D. Cowan, K. Conway, et al. 2006. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502.
3. Lund, M. J., K. F. Trivers, P. L. Porter, R. J. Coates, B. Leyland-Jones, O. W. Brawley, et al. 2009. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res. Treat. 113:357-370.
4. Ooi, S. L., M. E. Martinez, and C. I. Li . 2010. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res. Treat. 127:729-738.
5. Miller, B. A., K. C. Chu, B. F. Hankey, and L. A. Ries . 2008. Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S. Cancer Causes Control 19:227-256.
6. Brown, K. A., and E. R. Simpson . 2009. Obesity and breast cancer: progress to understanding the relationship. Cancer Res. 70:4-7.
7. Carmichael, A. R. 2006. Obesity and prognosis of breast cancer. Obes. Rev. 7:333-340.
8. Conroy, S. M., G. Maskarinec, L. R. Wilkens, K. K. White, B. E. Henderson, and L. N. Kolonel . 2011. Obesity and breast cancer survival in ethnically diverse postmenopausal women: the Multiethnic Cohort Study. Breast Cancer Res. Treat. 129:565-574.
9. Ewertz, M., M. B. Jensen, K. A. Gunnarsdottir, I. Hojris, E. H. Jakobsen, D. Nielsen, et al. 2011. Effect of obesity on prognosis after early-stage breast cancer. J. Clin. Oncol. 29:25-31.
10. Sinicrope, F. A., and A. J. Dannenberg . 2011. Obesity and breast cancer prognosis: weight of the evidence. J. Clin. Oncol. 29:4-7.
11. Protani, M., M. Coory, and J. H. Martin . 2010. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res. Treat. 123:627-635.
12. Maskarinec, G., Y. Takata, I. Pagano, L. Carlin, M. T. Goodman, L. Le Marchand, et al. 2006. Trends and dietary determinants of overweight and obesity in a multiethnic population. Obesity (Silver Spring) 14:717-726.
13. Flegal, K. M., M. D. Carroll, C. L. Ogden, and L. R. Curtin . 2010. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235-241.
14. Ogden, C. L., M. M. Lamb, M. D. Carroll, and K. M. Flegal . 2010. Obesity and socioeconomic status in adults: United States, 2005-2008. NCHS Data Brief 50:1-8.
15. Duggan, C., M. L. Irwin, L. Xiao, K. D. Henderson, A. W. Smith, R. N. Baumgartner, et al. 2011. Associations of insulin resistance and adiponectin with mortality in women with breast cancer. J. Clin. Oncol. 29:32-39.
16. Pollak, M. N., E. S. Schernhammer, and S. E. Hankinson . 2004. Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4:505-518.
17. Duggan, C., C. Y. Wang, M. L. Neuhouser, L. Xiao, A. W. Smith, K. W. Reding, et al. 2013. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int. J. Cancer 132:1191-1200.
18. Perks, C. M., and J. M. Holly . 2008. IGF binding proteins (IGFBPs) and regulation of breast cancer biology. J. Mammary Gland Biol. Neoplasia 13:455-469.
19. Renehan, A. G., J. Jones, C. S. Potten, S. M. Shalet, and S. T. O'Dwyer . 2000. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer. Br. J. Cancer 83:1344-1350.
20. Baron-Hay, S., F. Boyle, A. Ferrier, and C. Scott . 2004. Elevated serum insulin-like growth factor binding protein-2 as a prognostic marker in patients with ovarian cancer. Clin. Cancer Res. 10:1796-1806.
21. Probst-Hensch, N. M., J. H. Steiner, P. Schraml, Z. Varga, U. Zurrer-Hardi, M. Storz, et al. 2010. IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clin. Cancer Res. 16:1025-1032.
22. Rocha, R. L., S. G. Hilsenbeck, J. G. Jackson, A. V. Lee, J. A. Figueroa, and D. Yee . 1996. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J. Natl Cancer Inst. 88:601-606.
23. Yee, D., J. Sharma, and S. G. Hilsenbeck . 1994. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer. J. Natl Cancer Inst. 86:1785-1789.
24. Sheen-Chen, S. M., H. Zhang, C. C. Huang, and R. P. Tang . 2009. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray. Anticancer Res. 29:1131-1135.
25. Goodwin, P. J., M. Ennis, K. I. Pritchard, M. E. Trudeau, J. Koo, W. Hartwick, et al. 2002. Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes. Breast Cancer Res. Treat. 74:65-76.
26. Goodman, M. T., B. Y. Hernandez, S. Hewitt, C. F. Lynch, T. R. Cote, H. F. Frierson, Jr., et al. 2005. Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum. Pathol. 36:812-820.
27. Anderson, W. F., S. Luo, N. Chatterjee, P. S. Rosenberg, R. K. Matsuno, M. T. Goodman, et al. 2009. Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue respository of the Surveillance, Epidemiology, and End Results (SEER) program. Breast Cancer Res. Treat. 113:189-196.
28. Png, K. J., N. Halberg, M. Yoshida, and S. F. Tavazoie . 2012. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481:190-194.
29. Ooi, S. L., M. E. Martinez, and C. I. Li . 2011. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res. Treat. 127:729-738.
30. Foulstone, E. J., L. Zeng, C. M. Perks, and J. M. Holly . 2013. Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor. Endocrinology 154:1780-1793.
31. Schutt, B. S., M. Langkamp, U. Rauschnabel, M. B. Ranke, and M. W. Elmlinger . 2004. Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J. Mol. Endocrinol. 32:859-868.
32. Perks, C. M., E. G. Vernon, A. H. Rosendahl, D. Tonge, and J. M. Holly . 2007. IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells. Oncogene 26:5966-5972.
33. Juncker-Jensen, A., A. E. Lykkesfeldt, J. Worm, U. Ralfkiaer, U. Espelund, and J. S. Jepsen . 2006. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator. Growth Horm. IGF Res. 16:224-239.
34. Kim, D. S. C. H., S. K. Yang, J. W. Shin, C. H. Huh, and K. C. Park . 2009 May. Insulin-like growth factor-binding protein contributes to the proliferation of less proliferative cells in forming skin equivalents. Tissue Eng. Part A 15:1075-1080. doi: 10.1089/ten.tea.2008.0236
35. McCaig, C., C. A. Fowler, N. J. Laurence, T. Lai, P. B. Savage, J. M. Holly, et al. 2002. Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-beta) in normal vs cancerous breast epithelial cells. Br. J. Cancer 86:1963-1969.
36. Martin, J. L., S. M. Weenink, and R. C. Baxter . 2003. Insulin-like growth factor-binding protein-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J. Biol. Chem. 278:2969-2976.
37. Burrows, C., J. M. Holly, N. J. Laurence, E. G. Vernon, J. V. Carter, M. A. Clark, et al. 2006. Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Endocrinology 147:3484-3500.
38. Singh, B., D. Charkowicz, and D. Mascarenhas . 2004. Insulin-like growth factor-independent effects mediated by a C-terminal metal-binding domain of insulin-like growth factor binding protein-3. J. Biol. Chem. 279:477-487.
39. Lin, M. Z., K. A. Marzec, J. L. Martin, and R. C. Baxter . 2014. The role of insulin-like growth factor binding protein-3 in the breast cancer cell response to DNA-damaging agents. Oncogene 33:85-96.